Kymera Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $12.78 billion, with shareholders equity totaling $1.61 billion.
The company employs approximately 75 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Kymera Therapeutics Inc. reported $102.24 million in revenue, generating net income of $-349.43 million.
Key financial metrics include a P/E ratio of -36.58, a price-to-book (P/B) ratio of 7.92, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker KYMR.